Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Peroxisome proliferator-activated receptor gamma (PPARγ) is a key target for antidiabetic drugs like thiazolidinediones (TZDs).
• PPARγ has two distinct ligand-binding sites; the canonical site binds TZDs, while a second site binds oxidized vitamin E metabolites and garcinoic acid.
• The functional significance of this second binding site and its potential for noncanonical PPARγ regulation remain largely unexplored.

Purpose of the Study:

• To investigate the role of the second ligand-binding site on PPARγ activity.
• To develop selective ligands for this alternative binding site to probe its function.
• To understand the distinct regulatory mechanisms mediated by dual PPARγ binding.

Main Methods:

• Development of a selective ligand for the alternative PPARγ binding site.
• Investigation of simultaneous binding of orthosteric and alternative site ligands.
• Analysis of PPARγ-cofactor interactions using the selective ligand.
• Differential gene expression analysis to assess PPARγ signaling.
• Evaluation of effects on FOXO signaling pathways.

Main Results:

• An agonist mimicking dual vitamin E metabolite binding was identified.
• A selective ligand for the second PPARγ binding site was developed, revealing noncanonical regulation.
• Alternative site binding can occur concurrently with orthosteric ligands, altering PPARγ-cofactor interactions.
• This alternative binding lacks the pro-adipogenic effects of TZDs and does not activate classical PPAR signaling.
• Notably, alternative site binding significantly diminished FOXO signaling.

Conclusions:

• PPARγ possesses distinct regulatory mechanisms mediated by its two ligand-binding sites.
• Targeting the alternative binding site offers a novel approach for modulating PPARγ activity independently of classical pathways.
• The observed modulation of FOXO signaling suggests potential therapeutic applications for metabolic and other diseases.